Omeros Corporation Made Big Gain
Wed, Dec 24, 2025 at 07:19 PM
Omeros Corporation (OMER:NASDAQ) rocketted at $15.36, a gain of 75.5%. On Wed, Dec 24, 2025, OMER:NASDAQ touched a New 2-Week High of $15.36. The stock appeared on our News Catalysts scanner on Wed, Dec 24, 2025 at 10:33 AM in the 'BIOTECH' category. From Wed, Dec 10, 2025, the stock recorded 40.00% Up Days and 27.27% Green Days
About Omeros Corporation (OMER:NASDAQ)
Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
Top 10 Gainers:
- Omeros Corporation (OMER:NASDAQ), 75.54%
- SRAX, Inc. (SRAX:NASDAQ), 67.5%
- Santech Holdings Limited (STEC:NASDAQ), 59.38%
- Northann Corp. (NCL:NYSEMKT), 49.45%
- EUDA Health Holdings Limited (EUDA:NASDAQ), 44.27%
- Safe and Green Development Corporation (SGD:NASDAQ), 42.26%
- Dynavax Technologies Corporation (DVAX:NASDAQ), 38.19%
- Multi Ways Holdings Limited (MWG:NYSEMKT), 38.13%
- Indaptus Therapeutics, Inc. (INDP:NASDAQ), 33.84%
- Sidus Space, Inc. (SIDU:NASDAQ), 33.33%